260 related articles for article (PubMed ID: 29580781)
1. Elevated Urine Levels of Macrophage Migration Inhibitory Factor in Inflammatory Bladder Conditions: A Potential Biomarker for a Subgroup of Interstitial Cystitis/Bladder Pain Syndrome Patients.
Vera PL; Preston DM; Moldwin RM; Erickson DR; Mowlazadeh B; Ma F; Kouzoukas DE; Meyer-Siegler KL; Fall M
Urology; 2018 Jun; 116():55-62. PubMed ID: 29580781
[TBL] [Abstract][Full Text] [Related]
2. The bacterial microbiota of Hunner lesion interstitial cystitis/bladder pain syndrome.
Nickel JC; Ehrlich GD; Krol JE; Ahmed A; Sen B; Bhat A; Mell JC; Doiron RC; Kelly KL; Earl JP
BJU Int; 2022 Jan; 129(1):104-112. PubMed ID: 34143561
[TBL] [Abstract][Full Text] [Related]
3. Urine cytokines as biomarkers for diagnosing interstitial cystitis/bladder pain syndrome and mapping its clinical characteristics.
Jiang YH; Jhang JF; Hsu YH; Ho HC; Wu YH; Kuo HC
Am J Physiol Renal Physiol; 2020 Jun; 318(6):F1391-F1399. PubMed ID: 32281420
[TBL] [Abstract][Full Text] [Related]
4. Urine nerve growth factor (NGF) level, bladder nerve staining and symptom/problem scores in patients with interstitial cystitis.
Tonyali S; Ates D; Akbiyik F; Kankaya D; Baydar D; Ergen A
Adv Clin Exp Med; 2018 Feb; 27(2):159-163. PubMed ID: 29521057
[TBL] [Abstract][Full Text] [Related]
5. Urinary ATP may be a biomarker of interstitial cystitis/bladder pain syndrome and its severity.
Wu Y; He Y; Qi J; Wang S; Wang Z
Biomol Biomed; 2024 Jan; 24(1):170-175. PubMed ID: 37819233
[TBL] [Abstract][Full Text] [Related]
6. Potential Urine and Serum Biomarkers in Patients with Bladder Pain Syndrome/Interstitial Cystitis.
Wang L; Gao J; Zheng S; Wang Z; Zheng S; Luo Z
Arch Esp Urol; 2024 May; 77(4):353-358. PubMed ID: 38840277
[TBL] [Abstract][Full Text] [Related]
7. Increased urine and serum nerve growth factor levels in interstitial cystitis suggest chronic inflammation is involved in the pathogenesis of disease.
Liu HT; Kuo HC
PLoS One; 2012; 7(9):e44687. PubMed ID: 23028581
[TBL] [Abstract][Full Text] [Related]
8. Urinary nerve growth factor level is increased in patients with interstitial cystitis/bladder pain syndrome and decreased in responders to treatment.
Liu HT; Tyagi P; Chancellor MB; Kuo HC
BJU Int; 2009 Nov; 104(10):1476-81. PubMed ID: 19522864
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers in Interstitial Cystitis/Bladder Pain Syndrome with and without Hunner Lesion: A Review and Future Perspectives.
Akiyama Y
Diagnostics (Basel); 2021 Nov; 11(12):. PubMed ID: 34943475
[TBL] [Abstract][Full Text] [Related]
10. Macrophage migration inhibitory factor is increased in the urine of patients with urinary tract infection: macrophage migration inhibitory factor-protein complexes in human urine.
Meyer-Siegler KL; Iczkowski KA; Vera PL
J Urol; 2006 Apr; 175(4):1523-8. PubMed ID: 16516040
[TBL] [Abstract][Full Text] [Related]
11. Urine macrophage migration inhibitory factor (MIF) in children with urinary tract infection: a possible predictor of acute pyelonephritis.
Otukesh H; Fereshtehnejad SM; Hoseini R; Hekmat S; Chalian H; Chalian M; Bedayat A; Salman Yazdi R; Sabaghi S; Mahdavi S
Pediatr Nephrol; 2009 Jan; 24(1):105-11. PubMed ID: 18800229
[TBL] [Abstract][Full Text] [Related]
12. Pathology and terminology of interstitial cystitis/bladder pain syndrome: A review.
Akiyama Y; Homma Y; Maeda D
Histol Histopathol; 2019 Jan; 34(1):25-32. PubMed ID: 30015351
[TBL] [Abstract][Full Text] [Related]
13. Gene expression analysis of urine sediment: evaluation for potential noninvasive markers of interstitial cystitis/bladder pain syndrome.
Blalock EM; Korrect GS; Stromberg AJ; Erickson DR
J Urol; 2012 Feb; 187(2):725-32. PubMed ID: 22177197
[TBL] [Abstract][Full Text] [Related]
14. Neutrophil-to-lymphocyte ratio as a promising non-invasive biomarker for symptom assessment and diagnosis of interstitial cystitis/bladder pain syndrome.
Ke H; Zhu L; Wang Q; Xu K
BMC Urol; 2023 Nov; 23(1):180. PubMed ID: 37940904
[TBL] [Abstract][Full Text] [Related]
15. Small Fiber Polyneuropathy in Hunner Lesion and Non-Hunner Lesion Interstitial Cystitis/Bladder Pain Syndrome.
Han E; Killinger KA; Turner KM; Gilleran J; Tenney D; Peters KM
Female Pelvic Med Reconstr Surg; 2021 Jan; 27(1):e91-e95. PubMed ID: 32217920
[TBL] [Abstract][Full Text] [Related]
16. Urinary Biomarkers in Interstitial Cystitis/Bladder Pain Syndrome and Its Impact on Therapeutic Outcome.
Lin HY; Lu JH; Chuang SM; Chueh KS; Juan TJ; Liu YC; Juan YS
Diagnostics (Basel); 2021 Dec; 12(1):. PubMed ID: 35054241
[TBL] [Abstract][Full Text] [Related]
17. Current Understanding and Future Perspectives of Interstitial Cystitis/Bladder Pain Syndrome.
Ueda T; Hanno PM; Saito R; Meijlink JM; Yoshimura N
Int Neurourol J; 2021 Jun; 25(2):99-110. PubMed ID: 34218637
[TBL] [Abstract][Full Text] [Related]
18. Temporally complex inflammatory networks in an animal model reveal signatures for interstitial cystitis and bladder pain syndrome phenotype.
Shah AM; Vodovotz Y; Yoshimura N; Chermansky CJ; Fitzgerald J; Tyagi P
Neurourol Urodyn; 2023 Nov; 42(8):1839-1848. PubMed ID: 37587846
[TBL] [Abstract][Full Text] [Related]
19. Phenotyping of interstitial cystitis/bladder pain syndrome.
Akiyama Y; Hanno P
Int J Urol; 2019 Jun; 26 Suppl 1():17-19. PubMed ID: 31144756
[TBL] [Abstract][Full Text] [Related]
20. Peptidomics analysis reveals changes in small urinary peptides in patients with interstitial cystitis/bladder pain syndrome.
Abid MSR; Qiu H; Tripp BA; de Lima Leite A; Roth HE; Adamec J; Powers R; Checco JW
Sci Rep; 2022 May; 12(1):8289. PubMed ID: 35585122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]